| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 174.82B | 171.22B | 244.98B | 296.31B | 230.50B | 141.88B |
| Gross Profit | 20.37B | 19.91B | -9.30B | 25.72B | 22.85B | 24.56B |
| EBITDA | 12.53B | 13.25B | -14.84B | 20.73B | 17.63B | 19.72B |
| Net Income | 236.00M | 2.12B | -21.35B | 9.13B | 9.65B | 6.29B |
Balance Sheet | ||||||
| Total Assets | 149.04B | 153.38B | 148.61B | 172.10B | 157.16B | 127.88B |
| Cash, Cash Equivalents and Short-Term Investments | 25.55B | 33.61B | 19.67B | 33.62B | 27.16B | 31.70B |
| Total Debt | 46.17B | 45.22B | 57.78B | 55.64B | 53.60B | 47.68B |
| Total Liabilities | 79.88B | 80.90B | 93.01B | 98.15B | 90.34B | 73.38B |
| Stockholders Equity | 61.73B | 64.14B | 48.10B | 62.01B | 55.72B | 44.08B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 13.90B | -25.38B | 20.74B | -298.00M | 16.75B |
| Operating Cash Flow | 0.00 | 19.50B | -22.70B | 21.49B | 13.31B | 18.70B |
| Investing Cash Flow | 0.00 | -5.34B | -6.56B | -14.58B | -22.98B | -9.67B |
| Financing Cash Flow | 0.00 | -160.00M | 15.15B | -225.00M | 4.66B | 6.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥725.79B | 6.68 | 7.17% | 3.22% | -1.56% | 9.17% | |
71 Outperform | ¥221.74B | 13.52 | 13.70% | 2.36% | -1.60% | -10.41% | |
66 Neutral | ¥73.88B | 5.57 | ― | 1.79% | -15.80% | ― | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
63 Neutral | ¥57.79B | 3.56 | 4.73% | 2.31% | -1.96% | 33.15% | |
53 Neutral | ¥70.58B | 48.38 | 7.71% | ― | 28.85% | -9.70% | |
52 Neutral | ¥998.80B | 5.29 | -22.13% | ― | -2.28% | -794.92% |